QuickView for TK25;jsessionid=8C2ED186389585582270DBD8CC23FC32;jsessionid=2D48E769F0C38E61FF7BC1E1E4C5C616;jsessionid=278E11CC0EEE103721163EA59D740142;jsessionid=BC68229B91E6D1337995AB219EF1ED67;jsessionid=61929DF75495A22CBEA8A18379C699A6;jsessionid=5C0F4CDA21DF0119CCF49E22C716D46F (gene)

1. Effect of FGFR2 Alterations on Overall and Progression-Free Survival in Patients Receiving Systemic …
2. Noninvasive Detection of Polyclonal Acquired Resistance to FGFR Inhibition in Patients With Cholangi…
3. Fgfr2 is integral for bladder mesenchyme patterning and function.
4. Keratinocyte growth factor receptor: a therapeutic target in solid cancer.
5. Pemigatinib: Hot topics behind the first approval of a targeted therapy in cholangiocarcinoma.

There were no clinical trials for TK25;jsessionid=8C2ED186389585582270DBD8CC23FC32;jsessionid=2D48E769F0C38E61FF7BC1E1E4C5C616;jsessionid=278E11CC0EEE103721163EA59D740142;jsessionid=BC68229B91E6D1337995AB219EF1ED67;jsessionid=61929DF75495A22CBEA8A18379C699A6;jsessionid=5C0F4CDA21DF0119CCF49E22C716D46F